Together with our previous findings [6], the data suggest that CD57 expression on tumor-specific T cells does not always indicate terminal or near-terminal T cell differentiation and that it could, at least in part, also simply reflect a recent encounter with CD57+ tumor cells. This evidence concerns the gene B3GAT1 and neoplasm.